The simultaneous analysis of clofibric acid and probenecid and the direct analysis of clofibric acid glucuronide by high-performance liquid chromatography.
A rapid and selective high-performance liquid chromatographic method for the simultaneous quantitative analysis of clofibric acid and probenecid in plasma and urine and for the direct analysis of clofibric acid glucuronide in plasma is described. Both methods involve direct injection of deproteinised body fluids. Concentrations of as low as 10 mg/l of clofibric acid and probenecid and 1.5 mg/l of clofibric acid glucuronide can be measured by the analysis. The coefficient of variance for these methods ranges from 1--7%.
D002851:Chromatography, High Pressure Liquid / Q000379:methods; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000097:blood* / Q000652:urine; D005965:Glucuronates / Q000097:blood / Q000302:isolation & purification / Q000652:urine; D005966:Glucuronidase; D006801:Humans; D011339:Probenecid / Q000097:blood* / Q000652:urine
D005965:Glucuronates; D002995:Clofibric Acid; D005966:Glucuronidase; D002994:Clofibrate; D011339:Probenecid